Bon Natural Life (BON) Stock Price, News & Analysis

Company Overview

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.

Key Stats

• Today's Range: $1.55 to $1.69
• 50-Day Range: N/A
• 52-Week Range: $1.14 to $80.00
• Volume: 399,767 shs
• Average Volume: 2.22 million shs
• Market Capitalization: $267,350.30
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BON Stock Analysis - Frequently Asked Questions

How have BON shares performed this year?

Bon Natural Life's stock was trading at $1.80 on January 1st, 2025. Since then, BON shares have decreased by 9.4% and is now trading at $1.63.
View the best growth stocks for 2025 here.

When did Bon Natural Life IPO?

Bon Natural Life (BON) raised $11 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 2,200,000 shares at $5.00 per share. US Tiger Securities and Newbridge Securities Corporation served as the underwriters for the IPO and R. F. Lafferty was co-manager.

How do I buy shares of Bon Natural Life?

Shares of BON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Medicinal Chemicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:BON
• CIK: 1816815
• Web: N/A
• Phone: 0086-29-88346301
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $23.84 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 167,000
• Free Float: N/A
• Market Cap: $283,632.80
• Optionable: N/A
• Beta: -0.47